Facebook Instagram LinkedIn Twitter

Swiss Life Sciences Group

About
CBD
Our brands
Newsroom
Contact

Swiss Life Sciences Group

About
CBD
Our brands
Newsroom
Contact

CBD Investment

Demand for cannabidiol (CBD) for health and wellness purposes is growing

Admin@swisslife2. 12. 2021

Germany wants to legalise adult-use cannabis

Admin@swisslife22. 11. 2021

Luxembourg will legalise CBD

Admin@swisslife26. 10. 2021

Switzerland will legalise CBD

Admin@swisslife22. 10. 2021

CBD Oils Can Treat Chronic Pain, UK Study Finds

Admin@swisslife18. 10. 2021

Why invest in CBD?

Admin@swisslife12. 10. 2021

8 reasons to love CBD

Admin@swisslife8. 10. 2021

Justin Bieber next to launch his own CBD line with charitable focus

Admin@swisslife6. 10. 2021

Italy and it’s referendum on decriminalising cannabis

Admin@swisslife4. 10. 2021

CBD may reduce the adverse effects of anti-seizure drugs in people with epilepsy

Admin@swisslife1. 10. 2021

Posts navigation

1 2

At Swiss Life Sciences Group, we are dedicated to producing the highest quality, organic raw materials and products available in Europe today.

Sitemap

Social

Join us

For more information on how to get involved with Swiss Life Sciences Group, please leave your email address in the box below and submit.

Leave this field empty if you're human:

Terms & Conditions
Privacy Policy

© Swiss Life Sciences Group 2022 / Powered by Swiss Life Sciences Group Plc